Regarding the effects of bioresonance devices on cancer.
I. Core Mechanisms of Action
Interfering with Tumor Cell Metabolism:
Tumor cells exhibit abnormal bioelectromagnetic signals in their mitochondria and cell membrane ion channels. Bioresonance devices can emit specific frequencies of electromagnetic waves that resonate with tumor cells, interfering with their energy metabolism (e.g., inhibiting mitochondrial ATP production) and disrupting cell membrane stability, thereby inducing tumor cell apoptosis. Some cell experiments have shown that specific frequencies can regulate tumor-related pathways such as NF-κB and p53, inhibiting cell proliferation.
Regulating the Body's Immune Function:
By regulating the biological signals of immune cells (such as macrophages, T cells, and NK cells), it enhances the ability of immune cells to recognize tumor antigens, improves the immunosuppressed state of cancer patients, and helps to enhance the body's own anti-tumor capabilities.
Alleviating Treatment-Related Adverse Reactions:
For side effects such as nausea, vomiting, fatigue, and pain caused by radiotherapy, chemotherapy, and targeted therapy, it alleviates patient discomfort and improves quality of life by regulating autonomic nerve function and improving local microcirculation.
Assisting in Clearing Tumor-Related Abnormal Signals:
Some studies suggest that tumor tissue releases specific "pathological resonance signals." Bioresonance devices can collect and output antagonistic signals in reverse, clearing or weakening the impact of these abnormal signals on the body.
II. Clinical Application Guidelines and Recommendations
Role Positioning
It should only be used as a supplement to standard cancer treatment, to improve patients' quality of life and alleviate treatment side effects.
Applicable Population
Mainly applicable to advanced cancer patients (to alleviate symptoms and improve quality of life), or patients with weakened immunity after radiotherapy and chemotherapy (to assist in immune regulation).
Standard Usage Requirements
During treatment, tumor markers and imaging indicators should be regularly monitored to assess efficacy in a timely manner and avoid delaying standard treatment.
